(Press-News.org)
Chronic pain, a common and debilitating condition, often leads practitioners to prescribe opioids in escalating doses. The prescription of opioids has created a serious nationwide crisis that killed more than 107,000 Americans from December 2020 through December 2021, according to a report by the American Medical Association (“Nation’s opioid-related overdose and death epidemic continues to worsen”). Given these realities, an urgent need exists to develop novel non-opioid and non-addicting therapies capable of effectively managing chronic pain.
To help spur the development of these therapies, the National Institute of Neurological Disorders and Stroke at the National Institutes of Health recently awarded a five-year, $1.94 million grant (“Identification of novel lead EphB1/2 tyrosine kinase inhibitors targeting peripheral neuropathic pain’) to Mahmoud Salama Ahmed, Ph.D., from the Department of Pharmaceutical Sciences at the Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy. The project team includes TTUHSC department colleagues Jenny Wilkerson, Ph.D., (co-investigator) and Heba Ewida, Ph.D., and graduate student Harrison Benson.
In previous behavioral research studies, Ahmed’s laboratory demonstrated significant reversal of thermal hyperalgesia (heightened sensitivity to heat or thermal stimuli) and mechanical allodynia (pain from a light touch, pressure or movement) induced by experimental nerve damage and a sciatic nerve constriction injury.
Ahmed’s previous research also revealed the synergism of three tetracycline family members: minocycline, chlortetracycline and demeclocycline.
“That study showed the competitive inhibitory profile of chlortetracycline and the catalytic binding domain of EphB1 tyrosine kinase (transmembrane proteins that mediate communication between cells),” Ahmed explained. “It also showed that the tetracycline combination reversed thermal hyperalgesia and mechanical allodynia in various pain models. However, the IC50 (the amount of a drug needed to inhibit a biological process by 50%) for this approach is in the low micromolar range, requiring a near maximal dose of all three antibiotics in combination.”
A micromolar is one-millionth (10^-6) of a mole, which is a unit of measurement representing a specific number of molecules or atoms. For some drugs, concentrations this high in humans are difficult to achieve without producing unwanted side effects.
While working at UT-Southwestern, Ahmed published a paper at the proceedings of the National Academy of Sciences resolving the crystal structure of one of the tetracyclines with the EphB1 tyrosine kinase domain. Ahmed said this kinase is integrated into the progression of peripheral neuropathic pain.
“However, it doesn't make sense that when we have a patient that's suffering from a peripheral neuropathic pain, we will give them this combo of the tetracyclines,” Ahmed said. “Because in the long-term, some of the adverse effects the patient might develop include antibiotic resistance. Also, the binding of the tetracyclines to the kinase domain was not optimum. Based on that, I started to look at the structure again, and I came up with new structures to achieve more potency and selectivity.”
Ahmed then began collaborating with Wilkerson at TTUHSC. First, Ahmed’s lab conducted the design phase, synthesized (collected) other evidence and findings from past research and conducted biochemical validation. When the project was set to scale up and conduct in vivo, pre-clinical models, they turned to Wilkerson’s lab.
Wilkerson has 17 years of experience researching the involvement of the immune system in various chronic neuropathic pain models. Using this expertise, Wilkerson’s laboratory will examine the potency of these new compounds to reverse or prevent behaviors associated with chronic neuropathic pain. Her laboratory will also determine if therapeutically relevant doses of these new compounds produce untoward behavioral side effects.
“This project holds a lot of promise because, for so many people, opioids and gabapentinoids are the main options to treat chronic pain, and we know that these drugs often do not work to adequately control pain,” Wilkerson said. “Additionally, this project is very exciting because we might be able to prevent chronic pain from developing.”
As they prepare for this latest study, Ahmed said they have 50 to 60 molecules in hand that exhibit better activity when compared to the tetracyclines used to target the EphB1 tyrosine kinase domain. Two of these molecules are undergoing preclinical evaluation for reversing all the key parameters for peripheral neuropathic pain, such as thermal hyperalgesia and mechanical allodynia.
“The EphB1/2 tyrosine kinase domain inhibitors have the potential to reverse the thermal hyperalgesia and the mechanical allodynia, and those stimuli are interrelated to peripheral neuropathic pain,” Ahmed said. “Our overall goal is to pharmacologically examine whether selective EphB1/2 tyrosine kinase inhibition is necessary and sufficient to reverse and/or block peripheral neuropathic pain development.”
The Ahmed-Wilkerson team hypothesizes that their novel small molecules, which are not related to the tetracycline scaffold, will inhibit EphB1/2 tyrosine kinase signaling.
“These small molecules could prove to be novel tools to investigate the mechanisms that either block or reverse peripheral and central nervous system neuronal activation and nerve damage,” Ahmed said. “This will lead to decreased neuropathic pain-related biomarkers and behaviors associated with peripheral neuropathic pain.”
###
END
Psychedelic drugs are seeing a surge of interest from mainstream medicine, and initial results suggest that psychedelic-therapy can be a safe and effective treatment for some mental health conditions. However, the side-effect profile is still incompletely understood. In particular, the use of psychedelics has been posited to carry a risk of triggering latent psychotic disorders or persistent visual hallucination, known as Hallucinogen Persisting Perception Disorder (HPPD). In order to better understand the prevalence and risk factors of such side-effects, Katie Zhou and colleagues surveyed 654 people online who were planning to take psychedelics through their ...
Researchers from the Human Computer Interaction Institute (HCII) and Robotics Institute (RI) at Carnegie Mellon University introduced a novel method for fabricating functional flat-to-shape objects using a computer-controlled sewing machine.
The team includes Sapna Tayal, undergraduate student in the School of Design; Lea Albaugh, Mark Stehlik postdoctoral teaching fellow at HCII; James McCann, associate professor in RI; and Scott E. Hudson, professor and associate department head for education in HCII.
“Flat-to-shape” refers to objects that can be transformed from a flat sheet into a three-dimensional form through ...
A study in mice suggests that senescent cells are at least partially responsible for post-surgical delirium and similar conditions in elderly people—and identifies a combination of drugs that might be able to prevent the complication.
Elderly people sometimes experience neurocognitive problems after infections or surgeries. Shyni Varghese and colleagues investigated the role of cellular senescence in the neuroinflammation that occurs in these cases. Cellular senescence is a normal process that helps prevent abnormal cell proliferation, but it can also occur in response to stress. Senescent cells stop dividing and typically secrete pro-inflammatory cytokines and other molecules ...
The highs and lows of blood glucose aren’t just an energy rollercoaster; they could be a key to detecting diabetes risk early and spare you a needle prick or two.
Researchers at the University of Tokyo have identified a simple, noninvasive method for assessing blood glucose regulation — an essential factor in diabetes risk. Their approach, based on continuous glucose monitoring (CGM) data, could improve early detection and risk assessment for diabetes without relying on blood samples and expensive or complex procedures.
The ...
While much of the global research on menopause has focused on Western populations, the unique cultural, genetic, and lifestyle factors affecting Asian women during menopause have been largely overlooked. Key findings from a new white paper that surveyed 1,741 working women across five major Asia Pacific (APAC) countries—Singapore, Vietnam, Australia, Japan, and Indonesia titled ‘Menopause and the Bottom Line: A Critical Leadership Challenge for APAC Leaders’, published by NUS Bia-Echo Asia Centre for Reproductive Longevity and Equality (ACRLE) at the NUS ...
Insects are disappearing at an alarming rate worldwide, but why? Agricultural intensification tops the list of proposed reasons, but there are many other, interconnected drivers that have an impact, according to new research led by Binghamton University, State University of New York.
Research on insect decline has surged in recent years, sparked by an alarming 2017 study that suggested that insect populations had declined by 75% in less than three decades. This has led to countless published papers, with scientists hypothesizing different ...
Many people view their dog as a family member, friend, or kid, but does the relationship with them really resemble these human relationships? Researchers from ELTE Eötvös Loránd University now set out to explore the precise role dogs play in human social networks by comparing human-dog relationships with human-human relationships using 13 relationship scales.
Their study revealed that the owner-dog relationship can be interpreted as a mix of child and best friend relationships, combining positive aspects of the child relationship with the lack of negative aspects of friendship, blended with a high level of control over the dog. Interestingly, ...
Scientists at the VIB-UGent Center for Plant Systems Biology and VIVES University College have developed a new method to genetically improve poplar trees without introducing foreign DNA into its genome. This advancement could pave the way for faster and more widely accepted use of gene-edited trees in forestry and the bio-based economy. The work appeared in New Phytologist.
Gene editing without the baggage
Gene editing tools like CRISPR are revolutionizing plant science by allowing precise and targeted improvements ...
ANN ARBOR, Michigan, USA, 22 April 2025 – In a groundbreaking research study, University of Michigan researchers have discovered that a single dose of a psychedelic compound can enhance cognitive flexibility—the brain's ability to adapt to changing circumstances—for weeks after administration, potentially revolutionizing treatments for depression, PTSD, and neurodegenerative diseases.
The study, published today in the journal Psychedelics, demonstrates that mice treated with a single dose of 25CN-NBOH, a selective serotonin 2A receptor agonist, showed markedly ...
PISCATAWAY, New Jersey, USA, 22 April 2025 – In a comprehensive Genomic Press peer-reviewed research article, researchers have revealed compelling evidence that biological sex significantly influences substance use patterns among individuals with panic disorder, with implications for both clinical assessment and treatment strategies.
The noteworthy study, published today in the journal Genomic Psychiatry, examined associations between panic disorder and both alcohol and tobacco use disorders in a demographically diverse sample of nearly 11,000 individuals. The research team, led by Dr. Michele Pato from Rutgers University, ...
